Keeping high model for end‐stage liver disease score liver transplantation candidates alive
Jacqueline G. O’Leary, Susan L. Orloff, Josh Levitsky, Paul B. Martin, David P. Foley
Abstract
Jacqueline G. O’Leary, Susan L. Orloff, Josh Levitsky, Paul B. Martin, David P. Foley
Abstract
As the mean Model for End-Stage Liver Disease (MELD) score at time of liver transplantation continues to increase, it is crucial to implement preemptive strategies to reduce wait-list mortality. We review the most common complications that arise in patients with a high MELD score in an effort to highlight strategies that can maximize survival and successful transplantation.
OpenAlex reports 13 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
As the mean Model for End-Stage Liver Disease (MELD) score at time of liver transplantation continues to increase, it is crucial to implement preemptive strategies to reduce wait-list mortality. We review the most common complications that arise in patients with a high MELD score in an effort to highlight strategies that can maximize survival and successful transplantation.
Key concepts: Medicine, Liver transplantation, Model for End-Stage Liver Disease, Liver disease, Transplantation, Stage (stratigraphy), Waiting list, Internal medicine